Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Eli Lilly's One-Two Punch Could Knock Novo Nordisk Out of the Obesity Drug Fight
01:32pm, Saturday, 04'th Apr 2026
Foundayo (orforglipron) has a serious advantage over Novo Nordisk's Wegovy pill. Retatrutide, a subcutaneous triple hormone receptor agonist in phase 3 trials, could be a game changer.
India's 'Mounjaro brides': weight-loss injections become part of pre-wedding preparation
09:01pm, Thursday, 02'nd Apr 2026
Soon-to-be brides and grooms seeking shortcuts to shed pounds before the big day have become the latest consumer target for weight-loss drugs in India.
Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why
06:46pm, Thursday, 02'nd Apr 2026
In the most recent trading session, Eli Lilly (LLY) closed at $935.58, indicating a -1.98% shift from the previous trading day.
Market Today: Oil Jumps, SpaceX IPO, Tariff Shock
05:35pm, Thursday, 02'nd Apr 2026
Guru Stock PicksRichard Pzena has made the following transactions:Add in AMWD by 42.89%Private Capital has made the following transactions:Add in TH by 13.25%St
Trump Administration Unveils Up to 100% Tariff on Branded Drugs
05:34pm, Thursday, 02'nd Apr 2026
Drugmakers or countries that strike pricing deals or make manufacturing investment commitments in the U.S. can secure much lower levies, or none at all.
MSFT, AVGO, LLY & Other Stock Market Opportunities Amid U.S.-Iran War
03:30pm, Thursday, 02'nd Apr 2026
There's always opportunity in markets if you know where to look, says Tiffany McGhee. She offers insight into how her firm positions portfolios in times of profound volatility, including now as the U.
Global pharma companies that have publicly announced Trump drug pricing agreements
02:59pm, Thursday, 02'nd Apr 2026
U.S. President Donald Trump secured agreements with 16 major pharmaceutical companies to bring U.S. prescription drug prices in line with those paid in other developed nations in exchange for three-ye
Novo Nordisk Releases Data Showing 3.2% Greater Weight Loss vs Lilly Pill
02:26pm, Thursday, 02'nd Apr 2026
Eli Lilly (LLY) has secured FDA approval for its oral obesity therapy, Foundayo, pushing the company deeper into the next phase of weight-loss treatment as pill
Eli Lilly Stock Slips Despite Foundayo Approval As Geopolitical Tensions Weigh
09:34am, Thursday, 02'nd Apr 2026
Eli Lilly And Company (NYSE: LLY) shares are down approximately 1% Thursday despite FDA approval of its oral weight-loss drug Foundayo on Wednesday, as geopolitical tensions weigh on broader markets.
Lilly Pushes Back on Making Drug Price Deals Permanent
08:25am, Thursday, 02'nd Apr 2026
Eli Lilly (LLY, Financials) is drawing a clear line in the ongoing debate over drug pricing, warning that making current agreements permanent could create bigge
Lilly (LLY) Surges 3.8%: Is This an Indication of Further Gains?
08:06am, Thursday, 02'nd Apr 2026
Lilly (LLY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Wall Street sees multi-billion dollar debut for Lilly's obesity pill despite Novo lead
07:28am, Thursday, 02'nd Apr 2026
Eli Lilly's newly approved weight-loss pill is expected to generate billions in sales as soon as this year, with analysts betting it will quickly narrow Novo Nordisk's head start in the oral market
Prediction: This Will Be Eli Lilly's Next Billion-Dollar Growth Driver. (Hint: It's Not Weight Loss Drugs.
04:15am, Thursday, 02'nd Apr 2026
Eli Lilly has captured investors' attention in recent times thanks to its blockbuster weight loss drugs. The company dominates this valuable market in the U.S.
Eli Lilly and Company Target of Unusually Large Options Trading (NYSE:LLY)
01:28am, Thursday, 02'nd Apr 2026
Eli Lilly and Company (NYSE: LLY - Get Free Report) was the target of some unusual options trading on Wednesday. Stock investors acquired 50,761 call options on the company. This represents an increas
Why Eli Lilly Stock Trounced the Market Today
06:23pm, Wednesday, 01'st Apr 2026
It will compete directly with a similar product from rival Novo Nordisk. It remains to be seen which pill American users will prefer.
